These results indicated that FUI1 has high selectivity for uracil-containing ribonucleosides and imports uridine across cell-surface membranes, whereas FUN26 has broad nucleoside selectivity and most likely functions to transport nucleosides across intracellular membranes.
Nucleoside transporters are integral membrane proteins that mediate the uptake and release of nucleosides and nucleoside analog drugs (reviewed in Refs. [1] [2] [3] [4] . Among the earliest examples of transport systems genetically identified in Saccharomyces cerevisiae were those responsible for the uptake of purine and pyrimidine nucleosides and nucleobases (5, 6) . Whereas a great deal is now known about the proteins (FUR4, FCY2) responsible for nucleobase transport in S. cerevisiae, there is, as yet, little information about the proteins responsible for nucleoside transport. Although S. cerevisiae appears to lack the capacity for salvage of purine nucleosides and thymidine from the external environment, import of uridine across the cell surface has been observed in this organism (5, 6) . A nucleoside-specific vacuolar transport process with selectivity for adenosine and guanosine has also been identified in S. cerevisiae (7) . The molecular identity of these transport proteins has not, as yet, been unambiguously identified (7, 8) .
A variety of nucleoside transporters of higher (Homo sapiens and Rattus norvegicus) and lower (Escherichia coli) organisms have recently been identified by molecular cloning and functional expression in Xenopus laevis oocytes (9 -15) and in cultured cell lines (16) . Mammalian nucleoside transporters comprise two functionally and structurally distinct families, the concentrative nucleoside transporter (CNT 1 ), and equilibrative nucleoside transporter (ENT) proteins. CNTs mediate Na ϩ -dependent symport of nucleosides against their concentration gradients and are predicted to possess 8 -14 transmembranespanning domains, with 13 favored (17) . Thus far, two CNT subtypes, the pyrimidine-nucleoside selective (CNT1) and purine-nucleoside selective (CNT2) transporters, have been identified in mammalian tissues (10 -13, 18) . ENTs mediate bidirectional transport of nucleosides down their concentration gradients and are predicted to possess 11 transmembranespanning domains with large cytoplasmic loops between transmembrane-spanning domains 1 and 2 and 6 and 7. Two broadly selective ENT subtypes, which are subdivided based on their sensitivity (ENT1) or resistance (ENT2) to inhibition by nM concentrations of nitrobenzylmercaptopurine ribonucleoside (NBMPR), have been identified in both human (h) and rat (r) cells by molecular cloning (9, 14 -16) . hENT1 and hENT2 transport activities have been demonstrated to be present both at cell-surface membranes (19) and organellar membranes including mitochondria (20) , nuclear envelopes (21) , and lysosomes (22) .
Data base analysis of the S. cerevisiae genome indicated that the protein encoded by the yeast open reading frame YAL022c, termed FUN26 (function unknown now 26), shares limited amino acid identity (ϳ18%) with hENT1 and hENT2 (14, 15) . These observations suggested that FUN26 is a functional member of the ENT family of transporter proteins. FUN26, which was identified as a result of the sequencing of chromosome 1 of S. cerevisiae (23) , does not share sequence similarity with other yeast proteins and is predicted to have 517 amino acids (58.3 kDa) with 11 transmembrane-spanning domains, a large hydrophilic N-terminal tail (76 amino acids) and two large hydrophilic regions between transmembrane-spanning domains 1 and 2 (19 amino acids) and 6 and 7 (78 amino acids). FUN26 is not an essential protein because disruption of the gene (YAL022c) was not lethal (23) . FUI1 is a yeast protein, unrelated to FUN26, that has also recently been suggested to be a putative nucleoside transporter (8) . The locus encoding FUI1 (YBL042c), which is on chromosome 2, was originally identified from a mutant with increased resistance to the cytotoxic nucleoside analog 5-fluorouridine (6) . FUI1 is predicted to be a protein of 639 amino acids (72 kDa) with 10 transmembrane-spanning domains. The increased resistance to 5-fluorouridine of the fui1-disruption mutant led to the suggestion that FUI1 is a uridine transporter (8) and computer-assisted classification and functional assignment of known, and predicted, yeast facilitators placed FUI1 in the "uracil/allantoin" permease family (24, 25) . FUI1 shares 70 and 69% amino acid similarity with FUR4 (uracil permease) and DAL4 (allantoin permease), respectively. There is, as yet, no direct evidence that FUI1 encodes a membrane transporter with selectivity for uridine and/or uracil.
The present work was undertaken to determine the roles of FUN26 and FUI1 in the transport of uridine and other nucleosides in S. cerevisiae. Their involvement in the import of extracellular uridine was assessed by analysis of the effects of disruption of the FUN26 and FUI1 genes by insertional mutagenesis and reintroduction of the intact coding sequences in the pYES2 yeast expression vector on (i) 5-fluorouridine and 5-fluorouracil toxicities in plating studies, and (ii) inward fluxes of [ 3 H]uridine alone and in the presence of high concentrations (Ն1 mM) of a variety of nucleosides and nucleobases. FUI1 exhibited high affinity and selectivity for uridine and was shown to be the protein responsible for inwardly directed transport of uridine into S. cerevisiae. Expression of the FUN26 cDNA failed to confer uridine transport capability on yeast with the fui1 gene disruptions and was, therefore, tested in oocytes of X. laevis, because of the proven effectiveness of the latter system in the identification of nucleoside transport proteins (9 -15) . The functional characteristics of recombinant FUN26 produced in oocytes established that FUN26 accepts both purine and pyrimidine nucleosides, but not nucleobases, as permeants. A broadly selective nucleoside transport process has been described in yeast vacuolar membranes (7) . To determine if FUN26 localizes to internal membranes, the protein was tagged with the c-Myc immunoepitope, and yeast membrane fractions prepared by continuous sucrose gradient centrifugation were analyzed for the presence of recombinant FUN26myc by immunoblotting. The results presented here indicated separate roles of FUI1 and FUN26 in uridine metabolism, with FUI1 mediating uptake of uridine from the extracellular environment and FUN26-mediating uptake and/or release of uridine (and other nucleosides) from intracellular compartments.
EXPERIMENTAL PROCEDURES
Strains and Media-KY114 (MATa, gal, ura3-52, trp1, lys2, ade2, hisd2000) was the parental yeast strain used throughout. Polymerase chain reaction-mediated one-step gene disruption yeast mutants were generated by the method of Baudin (26) . Other strains were generated by transformation of the yeast/E. coli shuttle vector pYES2 (Invitrogen, Carlsbad, CA) into KY114 using a standard lithium acetate method (27) . cDNA inserts were under transcriptional control of the inducible GAL1 promoter wherein the promoter was either induced or repressed using galactose or glucose as carbon sources, respectively. Yeast strains were maintained in complete minimal medium (CMM) containing 0.67% yeast nitrogen base (Difco, Detroit, MI), amino acids (as required to maintain auxotrophic selection) and either 2% glucose (CMM/GLU) or 2% galactose (CMM/GAL). Agar plates contained CMM with various supplements and 2% agar (Difco, Detroit, MI). Plasmids were propagated in the E. coli strain TOP10F' (Invitrogen, Carlsbad, CA) and maintained in Luria broth (28) with ampicillin (50 g/ml).
Plasmid Construction-The FUI1 open reading frame was inserted into the yeast expression vector pYES2 to generate pYFUI1 using the primers (restriction sites underlined) 5Ј-FUI1sacI (5Ј-GCT GAG CTC ATG CCG GTA TCT GAT TCT GG-3Ј) and 3Ј-FUI1sphI (5Ј-GCA GCA TGC TTA GAT ATA TCG TAT CTT TTC ATA GC-3Ј). The FUN26 open reading frame was inserted into pYES2 to generate pYFUN26 using the primers (restriction sites underlined) 5Ј-FUNkpnI (5Ј-GCT GGT ACC ATG AGT ACT AGT GCG GAC ACT G-3Ј) and 3Ј-FUNsphI (5Ј-GCA GCA TGC CTA CCT GAT AAT AAA GTC AAT TAT G-3Ј). A version of FUN26 with the c-Myc immunoepitope at its C terminus was engineered to allow detection of the recombinant protein by immunoblotting. pYFUN26myc was generated using the primers (restriction sites underlined) 5Ј-FUNkpnI and 3Ј-FUNmyc (5Ј-GCA GCA TGC CTA CAA GTC CTC TTC AGA AAT GAG CTT TTG CTC CCT GAT AAT AAA GTC AAT TAT GAA G-3Ј). Chromosomal DNA from KY114, prepared as described previously (29), was used as the template for all polymerase chain reaction amplification reactions. The FUN26 gene disruption plasmid pYFUN26-HIS3 was generated by subcloning the blunted-HIS3(BamHI) fragment from pJJ215 into the blunted XhoI/PstI sites of pYFUN26. The FUI1 gene disruption plasmid was generated by subcloning the blunted TRP1(BglII) fragment from pAS5 (30) into the blunted BglII/AflI sites of pYFUI1. pAS5 and pJJ215 were generous gifts of Dr. B. Lemire, University of Alberta, Edmonton, AB. For functional expression of FUN26 and FUI1 mRNA in oocytes of X. laevis, the FUN26 and FUI1 open reading frames were subcloned into the Xenopus oocyte expression vector pSP64T (31) immediately downstream of the Xenopus ␤-globin 5Ј-untranslated region and immediately upstream of the Xenopus ␤-globin 3Ј-untranslated region, generating pGFUN26 and pGFUI1, respectively. The fidelity of all cDNA constructs was confirmed by sequencing the cDNA inserts, and the regions of the plasmids that included the cloning sites by standard cycle sequencing using an automated 310 Genetic Analyzer (PE Biosystems, Foster City, CA.)
Preparation of Yeast Membranes-Yeast membranes were prepared by a previously described method (32) in which yeast were grown to an optical density at 600 nm (A 600 ) of 0.8 -1.5, collected by centrifugation (500 ϫ g, 5 min, 4°C), washed three times with breaking buffer (10 mM Tris, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.1% (v/v) 2-mercaptoethanol, pH 7.4) that contained protease inhibitors (complete protease inhibitors, Roche Molecular Biochemicals), and lysed by vortexing in the presence of glass beads (425-600 m, Sigma-Aldrich Canada Ltd., Oakville, ON) for 15 min at 4°C. Unbroken cells and glass beads were removed from lysates by centrifugation (500 ϫ g, 5 min, 4°C), and membrane fractions were obtained by centrifugation of lysates (100,000 ϫ g, 60 min, 4°C). The resulting membrane pellets were resuspended in breaking buffer that contained protease inhibitors. The samples were either used immediately or frozen (Ϫ80°C) in breaking buffer.
Sucrose Gradient Centrifugation-Yeast membranes prepared as described above were fractionated on a continuous sucrose gradient as described elsewhere (33, 34) . Briefly, yeast crude membranes were layered on a 20 (w/w) to 53% (w/w) continuous sucrose gradient followed by centrifugation (18 h, 150,000 ϫ g, 4°C), and 1-ml portions of the gradient were removed and further centrifuged (60 min, 180,000 ϫ g, 4°C). The proteins present in the membranes (pellet) were separated electrophoretically and analyzed by immunoblotting (see below).
Electrophoresis and Immunoblotting-Yeast membranes that had been solubilized in urea were subjected to SDS-polyacrylamide gel electrophoresis (35) , after which proteins were transferred to polyvinylidene fluoride membranes (Immobilon-P, Millipore, Bedford, MA) that were subjected to the following treatments at 4°C: (i) incubation in TTBS (0.2% Tween-20, Tris-buffered saline) containing 5% (w/v) skim milk powder, (ii) incubation in TTBS with the primary antibody and 1% (w/v) skim milk powder, (iii) washing with TTBS, (iv) incubation with TTBS-containing species-specific horseradish-peroxidase secondary antibody (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) and 1% (w/v) skim milk powder, (v) washing with TTBS, and (vi) visualization with enhanced chemiluminescence (ECL, Amersham Pharmacia Biotech) and autoradiography. The primary antibodies used were 9E10 (anti-c-Myc, BAbCo, Richmond, CA.), PEP12 (prevacuolar marker, a generous gift of Dr. D. Hogue, B.C. Cancer Agency, Vancouver, B.C.) (36) , and PMA1 (plasma membrane marker, a generous gift of Dr. L. Fliegel, University of Alberta, Edmonton, AB) (37) .
Nucleoside Uptake in Yeast-The uptake of 3 H-nucleosides (purchased from Moravek Biochemicals, Brea, CA) by logarithmically proliferating yeast was measured as described previously (32) using the "oil stop" method (38, 39) with the following modifications. Yeast were grown in CMM/GLU or CMM/GAL to an A 600 of 0.8 -1.5, washed three times with fresh medium, and resuspended to an A 600 of 4. Transport reactions (conducted at room temperatures) were initiated by the rapid addition of 100-l portions of yeast cultures to 100-l portions of transport medium that contained 3 H-permeant and had been layered on a cushion of oil in a 1.5-ml microcentrifuge tube. Transport was terminated by centrifuging (12,000 ϫ g, 2 min, room temperature) yeast cells through the oil. The oil and unincorporated 3 H-permeant were removed by aspiration, and the pellets were solubilized with 5% Triton X-100 for determination of the radioactive content by scintillation counting.
Functional Expression of FUN26 and FUI1 in X. laevis Oocytes-In vitro synthesized transcripts were prepared from pGFUN26 and pG-FUI1 (SP6 MEGAscript Kit Ambion, Austin, TX) in water and injected into isolated mature stage VI oocytes from X. laevis as described previously (40) . Mock-injected oocytes were injected with water alone. Inward fluxes of 3 H-nucleosides (Moravek Biochemicals, Brea, CA) were measured by conventional tracer techniques (40) .
RESULTS

Sequence Relationships of Two Putative Nucleoside Transporter Proteins from S. cerevisiae-FUI1
, which was identified genetically as a uridine transporter (6, 8) , has high amino acid sequence identity with members of the "uracil/allantoin" permease family of S. cerevisiae (24, 25) . The high degree of sequence identity with DAL4 (allantoin permease), FUR4 (uracil permease), THI10 (thiamine permease), and three open reading frames that encode putative thiamine permeases suggested a functional relationship between FUI1 and the uracil/allantoin permeases. FUN26, the protein of unknown function predicted from the YAL022c open reading frame, has limited (ϳ18%) amino acid sequence identity with members of the ENT family of nucleoside transporters. The limited sequence identity of FUN26 with ENT proteins, first noted when the hENT1 and hENT2 cDNAs were cloned and functionally expressed (14, 15) , suggested that FUN26 may encode a nucleoside transporter of S. cerevisiae.
Disruption of the FUI1 and FUN26 Genes-The gene loci for FUI1 and FUN26 were disrupted by insertional mutagenesis (26) to allow determination of their functional characteristics independently of each other, taking advantage of the TRP1 Ϫ / HIS3 Ϫ phenotype of the KY114 yeast strain. The TRP1 sequence, encoding phosphoribosyl-anthranilate isomerase (EC 5.3.1.24), was inserted within the FUI1 coding sequence and the resulting fui1::TRP1 disruption fragment was introduced into KY114. The fui1-disruption mutants were selected in medium that lacked tryptophan. Similarly, the HIS3 sequence, encoding imidazoleglycerolphosphate dehydratase (EC 4.2.1.19), was inserted within the FUN26 coding sequence and the resulting fun26::HIS3 disruption fragment was introduced into KY114. The fun26-disruption mutants were selected in medium that lacked histidine. Polymerase chain reaction analysis of yeast chromosomal DNA prepared from either the parental strain or the TRP1 ϩ and HIS3 ϩ transformants confirmed disruption of the fui1 and fun26 loci, respectively.
Cellular Resistance to 5-Fluorouridine and 5-Fluorouracil by Yeast with FUI1 and FUN26
Gene Disruptions-Yeast are sensitive to 5-fluorouridine and 5-fluorouracil (6) and disruption of a gene encoding a cell-surface transport protein that mediates uptake of these drugs would be expected to impart resistance to cytotoxicity. The experiments of Fig. 1 were undertaken to determine if disruption of the fui1 and/or fun26 genes altered sensitivity to either 5-fluorouridine or 5-fluorouracil. When cultures of the parental (FUI1 ϩ , FUN26 ϩ ) strain and the fui1-disruption and fun26-disruption mutants were plated on solid medium that contained graded concentrations of 5-fluorouridine (Fig. 1a) , growth of the fui1-disruption mutant was observed at the highest (1 mM) concentration tested, whereas growth of the parental (FUI1 ϩ , FUN26 ϩ ) strain and the fun26-disruption mutant was inhibited at the lowest (10 M) concentration tested. When the fui1-disruption mutant was transformed with pYFUI1 and grown under inducing conditions, the resulting transformants exhibited even greater sensitivity to 5-fluorouridine than the parental (FUI1 ϩ , FUN26 ϩ ) strain. When the KY114 parental strain was transformed with pYFUN26 and grown under inducing conditions, the sensitivity to 5-fluorouridine was the same as observed for the parental strain (KY114). A similar result was obtained when the fui1-disruption mutant was transformed with pY-FUN26 and grown under inducing conditions. When similar plating experiments were undertaken with 5-fluorouracil, identical sensitivities were observed for all yeast strains and transformants (Fig. 1b) . Taken together, the results of Fig. 1 indicated a role, presumably involving inwardly directed transport across the plasma membrane, for FUI1, but not for FUN26, in 5-fluorouridine toxicity and no role for either FUI1 or FUN26 in 5-fluorouracil toxicity.
Uptake of Uridine by Yeast with FUI1 and FUN26 Gene Disruptions-To determine if the differences in 5-fluorouridine sensitivity observed in the experiments of Fig. 1 were related to uridine transport capacity, uptake of 1 M [ 3 H]uridine was measured into cells of the parental strain (FUI1 ϩ , FUN26 ϩ ) and the fui1-and fun26-disruption mutants (Fig. 2a). [
3 H]Uridine uptake was eliminated in the fui1-disruption mutant, whereas uptake in the fun26-disruption mutant was the same as that seen for the parental (FUI1 ϩ , FUI26 ϩ ) strain. These results were consistent with the conclusion that FUI1, and not FUN26, was responsible for the uridine transport activity observed in the parental (FUI1 ϩ , FUN26 ϩ ) strain. The ability of recombinant FUI1 to reconstitute uridine transport activity in the fui1-disruption mutant was assessed by measuring the uptake of 1 M pYFUI1 and grown under inducing conditions (Fig. 2b) . [ 3 H]Uridine uptake was greatly stimulated in pYFUI1-containing yeast, and this uptake was eliminated in the presence of a great excess (10 mM) of nonradioactive uridine. In contrast, reconstitution of uridine transport activity was not observed when pY-FUN26 was introduced into the fui1-disruption mutant (Fig. 2c) .
The overexpression of the FUI1 cDNA in the fui1-disruption mutant allowed the kinetic characterization of uridine transport mediated by recombinant FUI1 in a fui1-null background (Fig. 2d) . The fui1-disruption mutant harboring pYFUI1 was grown under inducing conditions, and the initial rates of uptake were determined over a range of [ 3 H]uridine concentrations. Uridine transport was saturable with K m and V max values (mean Ϯ S.D.), respectively, of 22 Ϯ 3 M and 3500 Ϯ 240 pmol/mg of protein/s, indicating that FUI1 is a high affinity uridine transporter.
Detailed structure-activity studies were undertaken to identify compounds that inhibited FUI1-mediated uridine transport activity and were therefore candidate permeants. The transport of 1 M [ 3 H]uridine was measured in the absence or presence of high concentrations of (i) nucleosides, nucleobases, and ribose; (ii) uridine and uridine analogs; (iii) substrates of the uracil/allantoin family of yeast permeases; or (iv) ENT transport inhibitors. The results of Table I indicated that FUI1-mediated [ 3 H]uridine uptake was inhibited completely by uridine and partially by uracil, 5-fluorouracil, and thymine, but not by ribose or the other nucleosides tested. The results of Table I also indicated that FUI1-mediated [ 3 H]uridine uptake was inhibited completely by uridine, strongly by uridine analogs (uridine Ͼ 5-fluorouridine ϭ 2Ј-deoxyuridine ϭ 5-fluoro5Јdeoxyuridine), and to a lesser extent by other uridine analogs (5-fluoro-2Ј-deoxyuridine ϭ 5-bromo-2Ј-deoxyuridine ϭ 5-methyluridine ϭ 5-iodouridine). Although high concentrations of uracil inhibited FUI1-mediated transport partially, the other substrates (allantoin, thiamine) of the uracil/allantoin permease were without effect when tested at 10 mM. Similarly, FUI1-mediated transport was not inhibited by dilazep, dipyridamole, or NBMPR, the "classic" inhibitors of the mammalian ENT family of proteins (4) . Together, the experiments of Table  I demonstrated that FUI1 is a uridine-specific transporter with (i) preferences for uridine over uracil and the ribosyl over the deoxyribosyl moiety of uridine and (ii) a low tolerance for modification of the 5-position on the pyrimidine base of uridine.
Production of Recombinant FUN26 in X. laevis OocytesDespite the absence of FUN26-mediated uptake of extracellular uridine by yeast, the sequence similarity of FUN26 to the ENT proteins of mammalian cells suggested that FUN26 might be a nucleoside transporter. Thus, recombinant FUN26 was produced and tested in oocytes of X. laevis using established procedures for functional expression of ENT proteins (9, 15) . The uptake of 20 M 3 H-nucleoside or 3 H-nucleobase was measured over 60 min in oocytes that had been injected with FUN26 transcripts in water or water alone (Fig. 3a) Production of FUN26myc in Yeast-The production of functional recombinant FUN26 in X. laevis oocytes indicated that FUN26 exhibits the capacity for uridine transport. However, cell surface FUN26-mediated uridine transport activity was not detected in yeast using indirect (plating assays) or direct ([ 3 H]uridine transport) methods in either loss of function experiments (fun26-disruption mutant) or gain of function (pY-FUN26-harboring yeast) experiments. To further characterize the biological role of FUN26 in yeast, an immunotagged (c-Myc) version of FUN26 was generated (FUN26myc) to permit localization of the recombinant protein in yeast. Membranes were prepared from yeast harboring pYFUN26myc or pYES2 that had been grown under inducing conditions (CMM/GAL) and subjected to immunoblotting with the 9E10 c-Myc monoclonal antibody (Fig. 4a) . A predominant 55-kDa and a minor 30-kDa immunoreactive species were detected in membranes of pYFUN26myc-containing yeast (lane 2) that were not present in membranes of pYES2-containing yeast (lane 1). The predicted molecular mass of FUN26 is 58.3 kDa, suggesting that the predominant species observed in lane 2 was FUN26myc and the minor species was a degradation product thereof. Addition of the c-Myc epitope did not affect the function of the protein, because production of recombinant FUN26myc in X. laevis oocytes stimulated [ 3 H]uridine uptake to the same extent as recombinant FUN26 (data not shown). combinant FUN26myc was assessed by density gradient fractionation. Membranes from yeast (KY114) harboring pYFUN26myc and grown in inducing (CMM/GAL) conditions were prepared and subjected to continuous sucrose gradient (20 -53% (w/w)) centrifugation. Fractions from the gradient were subjected to immuoblotting (Fig. 4b ) using antibodies against (i) the c-Myc epitope (to detect FUN26myc), (ii) PMAI (a yeast plasma membrane marker) (37) and PEP12 (an intracellular, prevacuolar membrane marker) (36) . The plasma membrane marker (PMA1) displayed a characteristic distribution throughout the sucrose gradient that has been described previously (33, 34) , whereas the intracellular membrane marker (PEP12) was distributed in greatest abundance in just two or three fractions. Recombinant FUN26myc displayed a distribution that was distinct from that of PMA1 but closely resembled that of the distribution of PEP12, suggesting that recombinant FUN26myc was predominantly present in intracellular membranes.
FUN26myc Is Predominantly Located in Intracellular Mem
DISCUSSION
Sequence comparisons have identified an open reading frame (YBL042c) that is predicted to encode a protein (FUI1) that belongs to the uracil/allantoin permease family (24, 25) . Recently, indirect evidence has shown that disruption of the FUI1 gene locus leads to increased resistance to the cytotoxic nucleoside analog 5-fluorouridine (8) Candidate permeants and/or inhibitors of FUI1 were identified by assessing inhibition of FUI1-mediated [ 3 H]uridine transport in the absence or presence of a high concentration of the test compound. FUI1 was shown to: (i) prefer uridine over uracil, (ii) prefer a hydroxyl group on the 2Ј-position of the ribosyl over the deoxyribosyl moiety of nucleosides, and (iii) have a low tolerance for substitutions (F-, Br-, CH 3 -, I-) at the 5-position of the base. FUI1-mediated [ 3 H]uridine transport was not inhibited by purine nucleosides, hypoxanthine, or ribose, indicating that none of these compounds are accepted as permeants or inhibitors. FUI1 also lacked sensitivity to inhibition by NBMPR, dilazep, and dipyridamole. Finally, although FUI1 shares high sequence identity with other members of the uracil/allantoin permease family, it did not display overlapping substrate selectivities with other family members.
Analysis of the S. cerevisiae genome identified the open reading frame YAL022c (FUN26) as encoding a protein that is a structural member of the ENT family of membrane proteins, suggesting that there might be conservation of function be- tween FUN26 and ENT family members. Recombinant nucleoside transport proteins from a variety of organisms have been functionally produced in oocytes of X. laevis (9, 11, (13) (14) (15) , and we used this expression system to determine if the FUN26 protein has nucleoside transport activity. Recombinant FUN26 protein mediated transport of a variety of nucleosides (e.g. adenosine, cytidine, uridine, inosine, and thymidine), whereas nucleobases (e.g. uracil and hypoxanthine) were not transported. FUN26-mediated [ 3 H]uridine transport activity was independent of pH, a feature characteristic of mammalian ENT family members. FUN26-mediated transport activity was not inhibited by NBMPR, dilazep, or dipyridamole, potent, and well studied inhibitors of mammalian ENTs. These results suggested that FUN26 shares structural features with ENT family members that confer nucleoside transport capability but not inhibitor sensitivity.
Disruption of the gene encoding FUN26 did not change the capacity of yeast for uptake of extracellular uridine. This apparent lack of FUN26-mediated, cellular uptake of uridine by yeast harboring pYFUN26 and grown under inducing conditions suggested that recombinant FUN26 was either (i) not produced or (ii) produced but not present at the cell surface.
Western blot analysis of yeast membranes prepared from pYFUN26myc-containing yeast that were grown under inducing conditions demonstrated that recombinant FUN26myc was present in yeast membranes. Fractionation and immunoblotting of yeast membranes containing FUN26myc demonstrated that FUN26myc was not present in plasma membranes but rather co-localized predominantly with a marker of late endosomes (PEP12). Thus, it appeared that FUN26 nucleoside transport activity was not detected at the cell surface because FUN26 resides in intracellular membranes, possibly including those of the late endosomal/vacuolar compartment.
In S. cerevisiae, the vacuole serves the role of, and has long been considered to be identical to, the mammalian lysosome (41) . In yeast the vacuole serves as the site of degradation of macromolecules, and a variety of integral membrane proteins of the vacuolar membrane are responsible for the uptake and release of vacuolar contents. Transport processes that have been previously identified in yeast vacuoles include those for amino acids (42, 43) , phosphate (44) , calcium (45) , glutathione conjugates (46) , and nucleosides (7). Direct measure of 3 Hnucleoside transport in vacuoles isolated from S. cerevisiae has identified nucleoside transport process(es) involved in the uptake and release of adenosine and guanosine (7) . Similarly, the nucleoside transport activity of human lysosomes resembles that of an ENT protein (22) .
The results presented here suggested that FUI1 and FUN26 mediate cell surface and intracellular nucleoside transport, respectively, in S. cerevisiae. Functional analysis of the fui1 gene product in S. cerevisiae indicated that FUI1 is highly selective for uridine and may serve as the predominant salvage route of extracellular uridine. Production of recombinant FUN26 in the oocyte expression system indicated that the FUN26 protein has nucleoside transport activity of broad specificity even though fun26 gene disruption and overexpression had no detectable effect on import of extracellular uridine into yeast. Immunodetection revealed co-localization of recombinant FUN26 predominantly with a marker of late endosomes and to a much lesser extent with a marker of plasma membranes. Analysis of all known genes in S. cerevisiae for their expression during the cell cycle has determined that FUN26 mRNA is most abundant during M phase (47) . Thus, a possible role of FUN26 is the vacuolar release of nucleosides (e.g., adenosine, uridine, and cytidine) produced by vacuolar catabolism of nucleic acids during the period of rapid RNA and DNA synthesis leading up to cell division.
